Jim Mullen won a $20M option package when he switched from chairman to the CEO job at Editas — and it's all tied to performance

The last time James Mullen ran a biopharma company, he was roasted by Carl Icahn for drawing tens of millions of dollars in compensation at …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Jim Mullen won a $20M op­tion pack­age when he switched from chair­man to the CEO job at Ed­i­tas — and it's all tied to per­for­mance